$PRQR News

ProQR Therapeutics N.V. (PRQR) Presents at 29th ASGCT Annual Meeting 2026 - Slideshow

ProQR Therapeutics N.V. (PRQR) Presents at TIDES USA 2026 - Slideshow

ProQR Therapeutics Q1 EPS $(0.15), Inline, Sales $2.381M Miss $5.530M Estimate

ProQR Therapeutics: Waiting On Proof As AX-0810 Data Approaches

ProQR Highlights Pipeline Expansion and Multiple Upcoming Clinical Catalysts at Investor and Analyst Event

ProQR Therapeutics N.V. (PRQR) Shareholder/Analyst Call Transcript

ProQR Therapeutics Unveils New RNA Editing Programs; AX-0810 Phase 1 Target Data Due This Quarter

ProQR Therapeutics Announces Key Updates During Virtual Event; Emphasizes Expansion Of Pipeline With Two New Programs And Leading RNA Editing Program On Track For Target Engagement Data

ProQR Therapeutics Announces Key Updates During Virtual Event; Emphasizes Expansion Of Pipeline With Two New Programs And Leading RNA Editing Program On Track For Target Engagement Data

ProQR Therapeutics N.V. (PRQR) Shareholder/Analyst Call - Slideshow

ProQR Announces Partnership with Ginkgo Bioworks and Formation of AI Advisory Board

April 2026 Penny Stock Highlights

Oppenheimer Predicts Up to ~560% Rally for These 2 ‘Strong Buy’ Stocks

ProQR to Host Virtual Investor and Analyst Event Highlighting Pipeline on April 8, 2026

ProQR Therapeutics N.V. (PRQR) Presents at The Citizens Life Sciences Conference 2026 Transcript

ProQR Therapeutics Q4 EPS $(0.09) Misses $(0.08) Estimate, Sales $5.458M Miss $8.550M Estimate

ProQR (PRQR) Reports Q4 Loss, Lags Revenue Estimates

ProQR: Q4 Earnings Snapshot

Kamada (KMDA) Q4 Earnings and Revenues Miss Estimates

Opus Genetics, Inc. (IRD) Reports Q4 Loss, Tops Revenue Estimates